Editors' Picks from the World Press

Pipeline/RD News

• Drugs in development could result in better hepatitis C treatment

Study on cancer genetics might help firms better design drug trials

GSK and Shionogi will move their AIDS drug into late-stage tests

Lundbeck and Gladstone will study drugs for neurological diseases

Business Finance

• UNITAID is in talks with makers of AIDS drugs about a patent pool
• Genzyme looks to divestment and "multiyear action" after a weak Q2
• Merck buys Hawaii Biotech's unit for a dengue fever vaccine
• Lilly finishes taking over biotech firm Alnara for as much as $380M

Government Legal News

• Drugmakers face greater pricing pressure from the EU's austerity drive
• Congressional inquiry cites China's lack of action on tainted heparin
• FDA issues a partial clinical hold on GSK's diabetes drug Avandia